EUVIMEDEUVIMED entdecken
Crossref

Discovery of new indole-thiazolidin-4-one hybrid derivatives as anticancer agents: Synthesis, biological evaluation, molecular docking toward VEGFR-2 , and DFT studies.

Zainab H. Alnakhli, Shorog M. Alotaiby, Hossa F. Alshareef, Nadiyah M. Alshammari, Arwa Alharbi, Samah J. Almehmadi, Adel I. Alalawy, Nashwa M. El-Metwaly

Arabian Journal of Chemistry · 03.11.2026 · 1-13

DOI: 10.25259/ajc_224_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arabian Journal of Chemistry, online erschienen am 03.11.2026. Verfasst von Zainab H. Alnakhli und 7 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of indole–thiazolidin-4-one hybrid derivatives ( IN-1–IN-5 ) was designed and synthesized as potential anticancer agents by integrating two biologically privileged scaffolds into a single molecular framework. The compounds were characterized using standard spectroscopic techniques and evaluated for their in vitro anticancer activity against human breast cancer cell lines (MCF-7 and MDA-MB-231) and WI-38 normal human lung cells using the Microculture Tetrazolium (MTT) assay, with doxorubicin (DXN) as the reference drug. All compounds exhibited concentration-dependent cytotoxic effects, with IC₅₀ values ranging from 20.54 ± 2.57 to 152.46 ± 3.43 µM for MCF-7 cells and from 13.30 ± 0.51 to 95.48 ± 2.83 µM for MDA-MB-231 cells. Among them, IN-5 was the most potent, showing IC₅₀ values of 20.54 ± 2.57 µM (MCF-7) and 13.30 ± 0.51 µM (MDA-MB-231), approaching the activity of doxorubicin. Structure–activity relationship analysis revealed that substituents on the imine nitrogen of the thiazolidinone ring significantly influence activity, with polar and hydrogen-bonding groups enhancing potency. Molecular docking studies against VEGFR-2 kinase demonstrated that IN-5 exhibited a favorable binding affinity (-8.62 kcal/mol), comparable to sunitinib (-8.36 kcal/mol), along with key interactions within the active site. Furthermore, density functional theory (DFT) calculations provided insight into the electronic properties and reactivity of the compounds. These findings identify IN-5 as a promising lead compound and highlight indole-thiazolidin-4-one hybrids as a valuable scaffold for the development of novel anticancer agents with potential VEGFR-2 inhibitory activity.

Zitieren

APA

Alnakhli, Z. H., Alotaiby, S. M., Alshareef, H. F., Alshammari, N. M., Alharbi, A., Almehmadi, S. J., Alalawy, A. I., & El-Metwaly, N. M. (2026). Discovery of new indole-thiazolidin-4-one hybrid derivatives as anticancer agents: Synthesis, biological evaluation, molecular docking toward VEGFR-2 , and DFT studies. Arabian Journal of Chemistry, 0, 1-13. https://doi.org/10.25259/ajc_224_2026

Vancouver

Alnakhli ZH, Alotaiby SM, Alshareef HF, Alshammari NM, Alharbi A, Almehmadi SJ, et al. Discovery of new indole-thiazolidin-4-one hybrid derivatives as anticancer agents: Synthesis, biological evaluation, molecular docking toward VEGFR-2 , and DFT studies. Arabian Journal of Chemistry. 2026;0:1-13. doi:10.25259/ajc_224_2026

BibTeX
@article{Alnakhli2026,
  author = {Alnakhli, Zainab H. and Alotaiby, Shorog M. and Alshareef, Hossa F. and Alshammari, Nadiyah M. and Alharbi, Arwa and Almehmadi, Samah J. and Alalawy, Adel I. and El-Metwaly, Nashwa M.},
  title = {Discovery of new indole-thiazolidin-4-one hybrid derivatives as anticancer agents: Synthesis, biological evaluation, molecular docking toward VEGFR-2 , and DFT studies},
  journal = {Arabian Journal of Chemistry},
  year = {2026},
  volume = {0},
  pages = {1--13},
  doi = {10.25259/ajc_224_2026}
}
Kostenlos starten →